TSCAN THERAPEUTICS INC TCRX
COM · Common Stock · CUSIP 89854M101
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersWaltham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($112.0k this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $3.15.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2021 | 28 |
| Q4 2021 | 30 |
| Q1 2022 | 26 |
| Q2 2022 | 25 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2021 | 11 | 13 |
| Q1 2022 | 12 | 11 |
| Q2 2022 | 13 | 9 |
Biggest buyers
| BAKER BROS. ADVISORS LP | Added | +1.4m |
| TANG CAPITAL MANAGEMENT LLC | Added | +547.8k |
| Newtyn Management, LLC | New | +248.6k |
| MORGAN STANLEY | Added | +18.0k |
| LPL Financial LLC | New | +16.0k |
| JANE STREET GROUP, LLC | New | +10.2k |
| CANNELL CAPITAL LLC | New | +3.7k |
| UBS Group AG | New | +1.1k |
| Tower Research Capital LLC (TRC) | Added | +1.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +942 |
Biggest sellers
| RA CAPITAL MANAGEMENT, L.P. | Sold out | -1.0m |
| HHLR ADVISORS, LTD. | Sold out | -669.5k |
| BARCLAYS PLC | Sold out | -158.9k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -13.3k |
| Woodline Partners LP | Reduced | -4.6k |
| BlackRock Inc. | Reduced | -4.2k |
| ROYAL BANK OF CANADA | Sold out | -1.0k |
| VANGUARD GROUP INC | Reduced | -865 |
| JPMORGAN CHASE & CO | Sold out | -361 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Lynx1 Capital Management LP 13G · passive investor -1.9 pts · filed 2026-08-14 | 13.1% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor no change · filed 2026-08-14 | 10.0% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 13G · institution filed 2025-02-12 | 7.1% |
| K2 HealthVentures Equity Trust LLC 13G · passive investor filed 2025-02-14 | 6.9% |
| Readout Capital, LP 13G · passive investor new · filed 2026-09-25 | 5.4% |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 6 | $21.7m | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 1 | $51.0k | 0 | — | — |
| Q2 2022 | 2 | $2.6m | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2022-05-18 | SOUTHWELL DAVID P Chief Executive Officer, director | Bought | $89.8k25.0k shares |
| 2022-05-11 | BAKER JULIAN +5 Director · See Footnotes | Bought | $51.5k25.9k shares |
| 2022-05-10 | BAKER JULIAN +5 Director · See Footnotes | Bought | $2.5m1.3m shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| BAKER BROS. ADVISORS LP 0.05% of their portfolio | 2.8m $8.8m | Added +1.4m |
| BlackRock Inc. 0.00% of their portfolio | 1.5m $4.8m | Reduced -4.2k |
| Deer Management Co. LLC 0.25% of their portfolio | 1.2m $3.9m | Unchanged |
| Alphabet Inc. 0.18% of their portfolio | 1.1m $3.4m | Unchanged |
| TANG CAPITAL MANAGEMENT LLC 0.36% of their portfolio | 747.8k $2.4m | Added +547.8k |
| DC Funds, LP 27.33% of their portfolio | 630.0k $2.0m | Unchanged |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.00% of their portfolio | 550.0k $1.7m | Unchanged |
| Newtyn Management, LLC 0.15% of their portfolio | 248.6k $782.0k | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 226.1k $711.0k | Reduced -865 |
| Tekla Capital Management LLC 0.02% of their portfolio | 200.0k $629.0k | Unchanged |
| Woodline Partners LP 0.01% of their portfolio | 132.3k $416.0k | Reduced -4.6k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 115.0k $362.0k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 57.1k $180.0k | Added +18.0k |
| DC Investments Management, LLC 0.25% of their portfolio | 35.6k $112.0k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 34.1k $107.0k | Added +942 |
| Marquette Asset Management, LLC 0.03% of their portfolio | 28.9k $91.0k | Unchanged |
| LPL Financial LLC 0.00% of their portfolio | 16.0k $50.0k | New |
| STATE STREET CORP 0.00% of their portfolio | 13.4k $42.0k | Added +800 |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 10.2k $32.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 9.0k $28.0k | Added +1.1k |
| CANNELL CAPITAL LLC 0.00% of their portfolio | 3.7k $11.0k | New |
| UBS Group AG 0.00% of their portfolio | 1.1k $4.0k | New |
| ATLAS CAPITAL ADVISORS INC. 0.00% of their portfolio | 896 $2.8k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 46 $0 | Added +5 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |